Early research (Phase 1)Study completedNCT00004032
What this trial is testing
Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer
Who this might be right for
Recurrent Ovarian Epithelial Cancer
National Cancer Institute (NCI) 12